Scientific Review Committee

Each of our Research Scholars Programs is overseen by a scientific review committee composed of distinguished experts in their respective fields who are independent from Gilead to ensure equal, objective evaluation of all applicants and their applications. This enables us to maintain the program’s overall integrity and competitive standards, and to ensure awards support the next generation of breakthrough scientific discovery.

Chair

Eriko Tokunaga, MD, PhD

Chief, Department of Breast Oncology
Kyushu Cancer Center

Review Committee

Yanin Chavarri Guerra, MD, PhD, MSc

Medical Researcher, Oncologist
Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán

Feng Yao, MD

Professor
Renmin Hospital of Wuhan University

Chief, Department of Breast Surgery
Renmin Hospital of Wuhan University, Hubei General Hospital

Rina Hui, MBBS, PhD

Professor
Centre of Cancer Medicine at University of Hong Kong

Honorary Consultant
Queen Mary Hospital

Carlos Barrios, MD

Director, Oncology Research Center
Hospital São Lucas-PUCRS

Cofounder, Director
Latin America Co-Operative Oncology Group (LACOG)

Başak Oyan Uluç, MD

Professor
Acibadem University

Medical Oncologist
Acıbadem Altunizade Hospital

Myung-Ju Ahn, MD, PhD

Professor, Division of Hemato-Oncology, Department of Medicine
Samsung Medical Center, Sungkyunkwan University

Review the scoring criteria considered for applications

Application Deadline

11:59 PM PDT

23 Mar 2026

Grant Amount

3 Awards

$130,000